Sequence of the intron/exon junctions of the coding region of the human androgen receptor gene and identification of a point mutation in a family with complete androgen insensitivity 
oligonucleotide primers to bracket coding exons for amplification by the polymerase chain reaction. Genomic DNA was amplified from 46,XY phenotypic female siblings with complete androgen insensitivity syndrome. AR binding affinity for dihydrotestosterone in the affected siblings was lower than in normal males, but the binding capacity was normal. Sequence analysis of amplified exons demonstrated within the AR steroid-binding domain (exon G) a single guanine to adenine mutation, resulting in replacement of valine with methionine at amino acid residue 866. As expected, the carrier mother had both normal and mutant AR genes. Thus, a single point mutation in the steroid-binding domain of the AR gene correlated with the expression of an AR protein ineffective in stimulating male sexual development.
cell cultures (23) (24) (25) . However, the study of natural mutations allows correlations not only between structure and function but also between structure and phenotype. For example, the molecular nature of a mutation in the AR gene has been recently reported in a family found to have a deletion of the entire steroid-binding domain (26) associated with loss of androgen-binding activity and complete AIS. Identification of natural gene deletions and point mutations offers an opportunity to study structural alterations in AR that affect sex differentiation, development, and reproductive function.
In this study, our aims were to determine the location of the hAR gene splice sites for comparison with other steroid receptors and to obtain the intron sequences flanking each exon to enable us to design oligonucleotide primers for exon DNA amplification by using the polymerase chain reaction (PCR) (27) . Amplification of exons made it possible to sequence the AR gene-coding regions of affected individuals in a family with complete AIS (28, 29) and revealed a single point mutation within the steroid-binding domain.
Androgens act through a receptor protein to promote differentiation and development of the male phenotype (1, 2) . The androgen receptor (AR) is a member of the steroid receptor family, which is part of a larger nuclear receptor superfamily (3) (4) (5) . These receptor proteins are related by sequence similarities within their "zinc finger" DNA-binding domains and by ligand-dependent regulation of specific gene transcription (3) (4) (5) . Complementary DNAs of many members of the nuclear receptor family have been cloned (refs. [3] [4] [5] and references therein and ref. 6), including the human receptors for thyroid hormone, retinoic acid, vitamin D, glucocorticoid, progesterone, mineralocorticoid, estrogen, and androgen (7) (8) (9) (10) (11) (12) (13) . Genomic clones have been described for the human estrogen (14) , human vitamin D (15), chicken thyroid hormone (16) , and chicken progesterone (17) receptors. To further understand the evolution and function of steroid receptors in eukaryotes and to identify mutations in the human AR (hAR) gene that cause the androgen insensitivity syndrome (AIS), we undertook to clone the AR gene.** In 46,XY individuals, X chromosome-linked androgen insensitivity results in a spectrum of developmental abnormalities ranging from a complete external female phenotype to partially masculinized ambiguous genitalia (1, 2, (18) (19) (20) (21) and may include some infertile males with apparently normal genitalia but defective spermatogenesis (22) . Mutations produced in vitro have allowed structure-function analyses of nuclear receptors by examining effects of these mutations in
MATERIALS AND METHODS
Isolation and Analysis of hAR Genomic Clones. Exon specific oligonucleotide probes were located within the AR cDNA by comparison of the hAR amino acid sequence (10) with the gene structure and amino acid sequence of the chicken progesterone receptor (cPR) (17) . These exon specific oligonucleotides and hAR cDNA fragments were used as probes to identify four genomic clones from a partial Sau3A, bacteriophage A Charon 35, flow-sorted, X chromosome genomic library (XLAOXNLO1, obtainable from the American Type Culture Collection). Exons C-H, contained within the clones, were isolated, subcloned, and sequenced as described for the isolation of exons A and B (7, 10) . Exon sequences of hAR were compared with exons of other steroid receptors by the GCG alignment program (30) .
Experimental Subjects. Informed written consent was obtained from each individual according to The Johns Hopkins Institutional Guidelines for Clinical Investigation. The three affected 46,XY siblings with complete AIS and their mother have been described (28, 29, 31, 32 
units) (Cetus) and each oligonucleotide at 20 AM were used per reaction. Amplification conditions consisted of an initial denaturing step at 950C for 5 min, annealing at 600C for 1 min, and polymerization at 720C for 6 min, followed by 30 cycles of 950C for 30 sec, 60'C for 1 min, and 720C for 6 min with a 3-sec increment per cycle in polymerization time. For oligonucleotide pairs A7-A8 and A9-A10, an annealing temperature of 650C reduced the number of nonspecific fragments. In addition, 60 cycles were used for oligonucleotide pair A7-A8, which amplifies a fragment with high G+C content. Amplified fragments of the correct size were ligated into blunt end M13 vectors and sequenced (7, 10) . Errors due to Taq polymerase misincorporation were detected by sequencing two independent clones of each orientation.
RESULTS AND DISCUSSION
Six genomic clones containing exons ofthe amino acid coding regions of the hAR gene were isolated from a human X chromosome A library by using hAR cDNA and synthetic oligonucleotide probes. Although the genomic clone inserts averaged 15 kilobases (kb) and the mRNA of hAR was 10-11 kb (7, 9, 10), only exons D and E and exons F, G, and H were found in the same clones (data not shown). Calculations based on five nonoverlapping clones averaging 15 kb yielded a size estimate of >75 kb for the hAR gene. Sequences of the hAR coding exons and flanking intron regions are shown in Fig. 1 . Cloned genomic exon and flanking intron sequences were confirmed by sequencing PCR amplified fragments of genomic DNA. Development of a method utilizing PCR for rapid analysis of mutations in the coding regions of the AR gene required that we sequence only far enough into the flanking introns to allow selection of suitable synthetic oligonucleotide primers to bracket each exon. Thus, the large central regions of each intron remain to be sequenced.
N-Terminal Exons A
With the determination of the intron/exon splice junction sequences, both evolutionary and functional analyses of the hAR and its mutations are now possible. The intron/exon boundaries have the canonical splice consensus sequences (double underlined in Fig. 1) (33) . Splice sites of the hAR gene and those of human estrogen receptor (hER) (14) and cPR (17) genes are remarkably similar in location and flanking amino acid sequences (data not shown). By comparison with other homologous steroid receptor cDNAs and cloned steroid receptor genes (hAR, cPR, hER, and hMR) (MR, mineralocorticoid receptor), the probable splice sites of the other as yet unreported steroid receptor gene sequences (hPR, hMR, and hGR) (GR, glucocorticoid receptor) could be predicted. Comparisons of their exons reveal regions of evolutionary conservation of essential functions (Fig. 2) .
The most highly conserved exons, B and C, encode the first and second zinc finger motifs, respectively, and make up the DNA-binding domain (3) (4) (5) . Within these and other exons, sequence identity of hAR is closer to hPR, hMR, and hGR than to hER (Fig. 2) . Only the second zinc finger exon of hER, exon C, has a high degree of sequence similarity with hAR. The large N-terminal domain contained within the A exon has little similarity with other receptors. This exon appears to contain a transcription-enhancing function and may also modulate DNA binding (3) (4) (5) . Neither exon A nor exons B and C are known to have any influence on ligand binding.
In the ER and GR, it has been demonstrated that the steroid-binding domain encompasses exons E-G and portions of exons D and H (23, 24) . hAR exons E-G exhibit a relatively high degree of similarity to hPR, hMR, and hGR (Fig. 2) . Although exon D is less homologous overall, a 23-amino acid region positioned near its 3' junction is highly conserved among all nuclear receptors (10) . Experimental mutations within this region were found to interfere with ligand binding, suggesting that it is part of a hydrophobic ligand-binding pocket (23, 24, 34 (10) is compared by exon with amino acid sequences of the hPR, hMR, hGR, and hER (refs. 3-5 and references therein and ref. 6 ). Indicated are the percent homologies with hAR (boxed) and amino acid residue numbers (below boxes). Intron/exon splice sites are indicated by the vertical dashed lines. Amino acid residue numbers of the splice sites of hAR (this report), hER (14) , and the exon B splice sites of hMR (6) are known. hPR splice sites were derived from sequence homology with the known splice sites of cPR (17) . The splice sites of hGR and the remaining splice sites of hMR were derived from sequence homology with hAR. Amino acid sequences ofthe predicted splice sites with the exception ofthe exon A/B sites were homologous (data not shown). Percent homologies among the same exons of different receptors were calculated by the GAP program of the GCG sequence analysis program (30 GR, and ER have been shown to result in decreased steroid binding and transcriptional activation (23) (24) (25) .
As a first step in understanding further the structurefunction relationships of AR at the molecular level, we analyzed a family with complete AIS. For a prototypical study, we chose a family in which three 46,XY siblings expressed AR proteins with abnormal ligand-binding properties (28) . Affected individuals had the external female phenotype typical of complete AIS with adult male levels of circulating testosterone (31) and normal 5a-reductase activity in genital skin fibroblasts (28) . Saturation binding analysis with [3H]dihydrotestosterone indicated normal amounts of AR in genital skin fibroblasts, and the AR protein had a normal 8S sedimentation rate by sucrose-density centrifugation (28) . However, AR binding affinity for [3H]dihydrotestosterone in affected 46,XY siblings was 3-fold lower than normal (Kd, 1.5 nM; normal, 0.5 nM) and the binding activity exhibited increased thermolability (28) . Moreover, AR affinity for progesterone was relatively higher than normal (2.5-fold) in binding displacement assays with [3H]dihydro- (28) . These findings suggested the presence of a mutation in the AR steroid-binding domain.
Southern blot analysis of genomic DNA with hAR cDNA probes spanning the coding region revealed no major deletion in the hAR gene of any member of this family (data not shown). Northern blot analysis of mRNA from one of the 46,XY siblings with AIS revealed the 7-kb and 10-to 11-kb mRNA species characteristic of hAR (data not shown). When we found no indication of a gross gene deletion or defect involving mRNA transcription in the three affected siblings of the present study, sequence analysis was performed to identify a small deletion or point mutation.
Oligonucleotides (underlined in Fig. 1 ) bracketing each of the amino acid coding exons were used as primers for PCR amplification of genomic DNA from one 46,XY sibling with complete AIS (II-1). All amplified exons produced fragments ofpredicted size (data not shown), verifying the Southern and Northern analyses that indicated the absence of a major hAR gene deletion. Sequence analysis of amplified exon DNA revealed a point mutation in exon G of the steroid-binding domain (Figs. 1, 3, and 4) . A guanine residue in the normal sequence was replaced by adenine, changing amino acid 866 from valine to methionine. No other amino acid sequence difference from normal was found in the entire 2757-base-pair AR coding region or in the flanking intron sequences, except within repeated glutamine and glycine regions of the A exon, where the numbers of glutamines, 22, and glycines, 15, differ from normal. However, variation in the numbers of these repeated amino acids has been found in all published sequences of the normal hAR receptor (10-13) and appears to result from an M13 sequencing artifact (data not shown) and/or to represent a normal polymorphism.
To confirm the hAR gene mutation, genomic DNA of exon G from the affected individual was reamplified and sequenced. In addition, genomic DNA from the other two affected siblings (11-2 and II-3) and their mother (I-1) was analyzed. Each contained the AR allele with a G replaced by an A, while their carrier mother contained, in addition, the normal allele (Fig. 4) . The valine to methionine alteration is therefore linked to AIS in this family.
CG dinucleotides, like those found at the locus mutated in this family with AIS ( Figs. 1 and 3) , are in humans sometimes methylated on the cytidine. Methylated cytidine can deaminate spontaneously to form thymidine. This may result in relative hot spots for the formation of mutations like those in the X chromosome-linked factor VIII gene, which cause hemophilia A (35) .
AR protein was expressed in normal amounts in these siblings with complete AIS as evidenced by the number of [3H]dihydrotestosterone-binding sites (28); however, binding affinity for androgen was decreased.tt There was also a relative increase in affinity for progesterone. Although hPR has a leucine at the position corresponding to the AR point mutation, cPR does contain a methionine, as do hGR and hMR (Fig. 3) . It is interesting to speculate that this region of the G exon may be important in determining steroid-binding specificity to AR. Estradiol has no increase in affinity for the mutated AR (28) , and its receptor has little homology with AR in exon G (Figs. 2 and 3) .
The exon G mutation has the potential of affecting both the steroid-binding and transcription-activating functions of the AR protein. Ligand binding to AR and other steroid hormone receptors initiates a transformation process that results in enhanced binding of receptors to their hormone response elements (3) (4) (5) . This process may involve a conformational change in the receptor protein or separation from a nonsteroid-binding component that unmasks the DNA-binding domain and a nuclear transfer sequence located in the Cterminal region downstream from the DNA-binding domain. The process may also activate within the steroid-binding domain a dimerization sequence shown to be required for strong interaction of the steroid receptor with its response element and for transactivation of gene expression (36, 37) .
The mechanism by which this point mutation, resulting in only a subtle change in steroid-binding properties of the AR, could cause complete loss of AR functional activity is not yet clear. However, it appears that complete transformation of the receptor subsequent to steroid binding requires precise structural interaction between receptor and ligand. Steroid antagonists, for example, have recently been shown to bind ERs and GRs and promote specific binding to hormone response elements without enhancing gene transcription as would a normal agonist (37, 38) . Hormone-binding domains of nuclear receptors are now recognized to have transcriptional enhancer effects (24, 38) . A point mutation might abolish this function without greatly affecting steroid binding. Expression of this mutated hAR in vitro will allow further studies to determine whether it is capable of binding to its response element and enhancing transcription of a reporter gene.
Present evidence suggests that there is a wide spectrum of AR gene mutations causing androgen insensitivity syndrome in humans (1, 2, 20, 21) . Such androgen receptor mutations are amenable to study by using the oligonucleotide primers and the PCR method described here. This method of analysis, by allowing correlations of AR structures with AIS phenotypes, should prove valuable in elucidating the mechanisms of action of AR in male sex differentiation and development.
Note Added in Proof. After submission of this paper, we learned of a publication (39) in which the structural organization of the hAR gene was partially determined. Their locations for the hAR gene splice sites are in agreement with the sites we have determined.
ttMore recently, we have recreated the natural mutation (amino acid 866, as shown in Fig. 3 ) in human AR cDNA by site-directed mutagenesis and expressed the mutated and wild-type hAR cDNAs in COS cells by a method previously described (7) . Binding affinity of the mutated AR for 3H-R1881 (a synthetic androgen) was -4-fold lower than that of the wild-type AR (data not shown). This difference in androgen-binding affinities is similar to that demonstrated earlier in cultured genital skin fibroblasts from normal males and from siblings with AIS in this family (28) .
